CLSN - .75 Celsion Announces Data Monitoring Committee Unanimously Recommends Continuation of Phase III OPTIMA Study of ThermoDox® for Primary Liver Cancer http://stockcharts.com/c-sc/sc?s=CLSN&p=D&b=5&g=0&i=t69805780809&r=1480514290073 http://stockcharts.com/c-sc/sc?s=CLSN&p=W&b=5&g=0&i=t23222318502&r=1480514300301